chiquitina
26/06/12 17:22
Ha respondido al tema
Farmas USA
ya te comente que le sacarias un pico a clsn y lo que le queda por venir con sus correcciones claro.
supn la seguia desde 19 despues de comentario de $heff SUPN..$5.09 Definitely on watch here. They have Two PDUFA dates on tap. One for July & October.
Our two epilepsy product candidates are SPN-538 (extended release topiramate), for which we submitted a new drug application, or NDA, that was accepted for filing by the U.S. Food and Drug Administration, or the FDA, in November 2011, and SPN-804 (extended release oxcarbazepine) for which we submitted an NDA that was accepted for filing by the FDA in February 2012. The Prescription Drug User Fee Act, or PDUFA, date for SPN-538 is in July 2012.n The PDUFA date for SPN-804 is in October 2012